MedPath
NMPA Approval

Metformin Hydrochloride and Vildagliptin Tablets(Ⅲ)

国药准字H20223339

May 25, 2022

Drug Information

二甲双胍维格列汀片(Ⅲ)

片剂

每片含盐酸二甲双胍1000mg与维格列汀50mg

化学药品

May 25, 2022

Company Information

Applicant Company

南京经济技术开发区恒竞路28号

Manufacturing Company

南京经济技术开发区恒竞路28号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

二甲双胍维格列汀片(Ⅲ) - NMPA 批准文号 | MedPath